(0.17%) 5 140.00 points
(0.10%) 38 479 points
(0.26%) 17 892 points
(-0.07%) $83.79
(1.09%) $1.944
(0.23%) $2 352.70
(0.45%) $27.66
(1.91%) $939.75
(-0.19%) $0.933
(-0.26%) $11.00
(-0.32%) $0.798
(1.28%) $93.05
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 6.23%
@ $37.43
发出时间: 10 Apr 2024 @ 03:35
回报率: -26.29%
上一信号: Apr 10 - 01:42
上一信号:
回报率: -0.27 %
Live Chart Being Loaded With Signals
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific...
Stats | |
---|---|
今日成交量 | 1.34M |
平均成交量 | 1.43M |
市值 | 3.30B |
EPS | $0 ( 2024-02-15 ) |
下一个收益日期 | ( $-0.460 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -12.66 |
ATR14 | $0.0170 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Saxonov Serge | Buy | 88 854 | Class A Common Stock |
2024-03-21 | Hindson Benjamin J. | Buy | 71 083 | Class A Common Stock |
2024-03-21 | Mcanear Justin J. | Buy | 53 312 | Class A Common Stock |
2024-03-14 | Saxonov Serge | Sell | 1 086 | Class A Common Stock |
2024-03-04 | Saxonov Serge | Sell | 4 660 | Class A Common Stock |
INSIDER POWER |
---|
5.12 |
Last 100 transactions |
Buy: 4 660 285 | Sell: 4 260 557 |
音量 相关性
10X Genomics Inc 相关性 - 货币/商品
10X Genomics Inc 财务报表
Annual | 2023 |
营收: | $618.73M |
毛利润: | $409.31M (66.15 %) |
EPS: | $-2.18 |
FY | 2023 |
营收: | $618.73M |
毛利润: | $409.31M (66.15 %) |
EPS: | $-2.18 |
FY | 2022 |
营收: | $516.41M |
毛利润: | $396.02M (76.69 %) |
EPS: | $-1.460 |
FY | 2021 |
营收: | $490.49M |
毛利润: | $416.40M (84.89 %) |
EPS: | $-0.576 |
Financial Reports:
No articles found.
10X Genomics Inc
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。